BIOMAT Database Logo BIOMAT Database Logo

[Clinical trials of Otrivin nose drops--experiences with infants and young children]. 1969

O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007223 Infant A child between 1 and 23 months of age. Infants
D007552 Isotonic Solutions Solutions having the same osmotic pressure as blood serum, or another solution with which they are compared. (From Grant & Hackh's Chemical Dictionary, 5th ed & Dorland, 28th ed) Solutions, Isotonic
D008297 Male Males
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D012220 Rhinitis Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES. Nasal Catarrh,Catarrh, Nasal,Catarrhs, Nasal,Nasal Catarrhs,Rhinitides
D014663 Nasal Decongestants Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) Decongestant,Decongestants,Nasal Decongestant,Vasoconstrictor Agents, Nasal,Vasoconstrictors, Nasal,Agents, Nasal Vasoconstrictor,Decongestant, Nasal,Decongestants, Nasal,Nasal Vasoconstrictor Agents,Nasal Vasoconstrictors

Related Publications

O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto
[Clinical experiences with the vasoconstrictor "Otrivin"].
April 1962, Wiener klinische Wochenschrift,
O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto
[NASAL DROPS FOR INFANTS AND YOUNG CHILDREN].
May 1965, HNO,
O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto
[Intoxication caused by nose drops in infants and small children].
January 1959, Deutsche medizinische Wochenschrift (1946),
O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto
[Clinical experiences with sulfonamide drops for children].
March 1974, Wiener medizinische Wochenschrift (1946),
O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto
[Adrenergic nose drops to infants].
October 1971, Ugeskrift for laeger,
O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto
[Toxic effect of tyzine nose drops in infants and small children].
August 1959, Die Medizinische,
O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto
[Nose drops as the cause of severe poisoning in infants and small children].
August 1961, Ugeskrift for laeger,
O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto
[CLINICAL TEST OF STRINGAN NOSE DROPS].
October 1964, Svenska lakartidningen,
O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto
[Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)].
April 1974, Zeitschrift fur Allgemeinmedizin,
O Mizukoshi, and T Imamura, and H Sasaki, and S Kawamoto
[Clinical experiences with timolol eye drops].
January 1979, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde,
Copied contents to your clipboard!